HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The leukemia-associated fusion protein MN1-TEL blocks TEL-specific recognition sequences.

Abstract
The leukemia-associated fusion protein MN1-TEL combines the transcription-activating domains of MN1 with the DNA-binding domain of the transcriptional repressor TEL. Quantitative photobleaching experiments revealed that ∼20% of GFP-tagged MN1 and TEL is transiently immobilised, likely due to indirect or direct DNA binding, since transcription inhibition abolished immobilisation. Interestingly, ∼50% of the MN1-TEL fusion protein was immobile with much longer binding times than unfused MN1 and TEL. MN1-TEL immobilisation was not observed when the TEL DNA-binding domain was disrupted, suggesting that MN1-TEL stably occupies TEL recognition sequences, preventing binding of factors required for proper transcription regulation, which may contribute to leukemogenesis.
AuthorsW Martijn ter Haar, Magda A Meester-Smoor, Karel H M van Wely, Claudia C M M Schot, Marjolein J F W Janssen, Bart Geverts, Jacqueline Bonten, Gerard C Grosveld, Adriaan B Houtsmuller, Ellen C Zwarthoff
JournalPloS one (PLoS One) Vol. 7 Issue 9 Pg. e46085 ( 2012) ISSN: 1932-6203 [Electronic] United States
PMID23049943 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Mn1 protein, mouse
  • Oncogene Proteins
  • Oncogene Proteins, Fusion
  • Proto-Oncogene Proteins c-ets
  • Repressor Proteins
  • Trans-Activators
  • Tumor Suppressor Proteins
Topics
  • Animals
  • Fluorescence Recovery After Photobleaching
  • Mice
  • Monte Carlo Method
  • NIH 3T3 Cells
  • Oncogene Proteins (genetics, metabolism)
  • Oncogene Proteins, Fusion (genetics, metabolism)
  • Protein Binding
  • Proto-Oncogene Proteins c-ets (genetics, metabolism)
  • Repressor Proteins (genetics, metabolism)
  • Trans-Activators
  • Tumor Suppressor Proteins
  • ETS Translocation Variant 6 Protein

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: